171 related articles for article (PubMed ID: 2891464)
21. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse.
Kuczenski R; Segal DS
Biol Psychiatry; 2005 Jun; 57(11):1391-6. PubMed ID: 15950013
[TBL] [Abstract][Full Text] [Related]
22. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
23. Integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD).
Horst RO; Hendren RL
Essent Psychopharmacol; 2005; 6(5):250-61. PubMed ID: 16222910
[TBL] [Abstract][Full Text] [Related]
24. Attention-deficit/hyperactivity disorder: an update.
Pary R; Lewis S; Matuschka PR; Lippmann S
South Med J; 2002 Jul; 95(7):743-9. PubMed ID: 12144081
[TBL] [Abstract][Full Text] [Related]
25. ADHD treatment across the life cycle.
Spencer TJ
J Clin Psychiatry; 2004; 65 Suppl 3():22-6. PubMed ID: 15046532
[TBL] [Abstract][Full Text] [Related]
26. Attention deficit disorder during adolescence: a review.
Faigel HC; Sznajderman S; Tishby O; Turel M; Pinus U
J Adolesc Health; 1995 Mar; 16(3):174-84. PubMed ID: 7779826
[TBL] [Abstract][Full Text] [Related]
27. [Attention-deficit/hyperactivity disorder (ADHS) in adulthood].
Kordon A; Kahl KG
Psychother Psychosom Med Psychol; 2004; 54(3-4):124-36. PubMed ID: 15037976
[TBL] [Abstract][Full Text] [Related]
28. Stimulant therapy in attention deficit/hyperactivity disorder.
Baldwin RL
J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
[TBL] [Abstract][Full Text] [Related]
29. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Faraone SV; Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
[TBL] [Abstract][Full Text] [Related]
30. Drugs under investigation for attention-deficit hyperactivity disorder.
Schweitzer JB; Holcomb HH
Curr Opin Investig Drugs; 2002 Aug; 3(8):1207-11. PubMed ID: 12211416
[TBL] [Abstract][Full Text] [Related]
31. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients.
Castaneda R; Levy R; Hazzi C; Ross S; Roman W; Hamid H
Gen Hosp Psychiatry; 2008; 30(6):572-7. PubMed ID: 19061685
[TBL] [Abstract][Full Text] [Related]
32. Treatment of attention deficit hyperactivity disorder in adults.
Greenfield B; Hechman L
Expert Rev Neurother; 2005 Jan; 5(1):107-21. PubMed ID: 15853481
[TBL] [Abstract][Full Text] [Related]
33. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
Kariyawasam SH; Zaw F; Handley SL
Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
[TBL] [Abstract][Full Text] [Related]
34. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
Wagner KD
Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
[TBL] [Abstract][Full Text] [Related]
35. Drug therapy in the treatment of minimal brain dysfunction.
Saccar CL
Am J Hosp Pharm; 1978 May; 35(5):544-52. PubMed ID: 26219
[TBL] [Abstract][Full Text] [Related]
36. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.
Noorbala AA; Akhondzadeh S
Arch Iran Med; 2006 Oct; 9(4):374-80. PubMed ID: 17061613
[TBL] [Abstract][Full Text] [Related]
37. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.
Correll CU; Kratochvil CJ; March JS
J Clin Psychiatry; 2011 May; 72(5):655-70. PubMed ID: 21658348
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of adult attention-deficit/hyperactivity disorder.
Post RE; Kurlansik SL
Am Fam Physician; 2012 May; 85(9):890-6. PubMed ID: 22612184
[TBL] [Abstract][Full Text] [Related]
39. Attention-deficit hyperactivity disorder: a clinical review.
Pliszka SR
Am Fam Physician; 1991 Apr; 43(4):1267-75. PubMed ID: 2008815
[TBL] [Abstract][Full Text] [Related]
40. Stimulant-atypical antipsychotic interaction and acute dystonia.
Benjamin E; Salek S
J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):510-2. PubMed ID: 15908830
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
